Friday, June 20th, 2025
Stock Profile: CELZ

Creative Medical Technology Holdings, Inc. (CELZ)

Market: NASD | Currency: USD

Address: 211 East Osborn Road

Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of Show more




📈 Creative Medical Technology Holdings, Inc. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2023 - $0.100000 - 2023-06-12 - Stock split
Total Amount for 2023: $0.100000
2021 - $0.002000 - 2021-11-10 - Stock split
Total Amount for 2021: $0.002000
2020 - $0.006667 - 2020-02-03 - Stock split
Total Amount for 2020: $0.006667


📅 Earnings & EPS History for Creative Medical Technology Holdings, Inc.


DateReported EPS
2026-03-12 (estimated upcoming)-
2025-11-06 (estimated upcoming)-
2025-11-05 (estimated upcoming)-
2025-08-07 (estimated upcoming)-
2025-08-06 (estimated upcoming)-
2025-05-08-
2025-05-07-
2025-03-19-
2025-03-14-1.12
2024-11-08-0.75
2024-08-09-1.11
2024-08-08-1.11
2024-05-10-0.73
2024-05-09-0.73
2024-03-22-1.19
2024-03-21-1.19
2023-11-13-1.02
2023-08-11-0.78
2023-08-10-0.78
2023-05-12-0.07
2023-05-11-0.07
2022-11-10-0.07
2022-11-09-0.07
2022-08-12-0.2
2022-08-11-0.2
2022-05-13-0.18
2022-05-12-0.18
2022-03-30-4.16
2022-03-29-4.16
2021-12-06-
2021-12-05-




📰 Related News & Research


No related articles found for "creative medical".